MOMI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 2.054
AS - Asia 1.524
EU - Europa 1.477
SA - Sud America 249
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.343
Nazione #
US - Stati Uniti d'America 2.017
SG - Singapore 696
IE - Irlanda 271
UA - Ucraina 250
IT - Italia 217
CN - Cina 213
RU - Federazione Russa 212
HK - Hong Kong 200
VN - Vietnam 197
BR - Brasile 188
SE - Svezia 123
DE - Germania 104
FR - Francia 84
FI - Finlandia 82
GB - Regno Unito 56
KR - Corea 40
TR - Turchia 32
IN - India 28
AR - Argentina 24
BD - Bangladesh 20
CA - Canada 17
PK - Pakistan 13
CO - Colombia 12
ES - Italia 12
UZ - Uzbekistan 12
ZA - Sudafrica 10
BE - Belgio 9
IQ - Iraq 9
MX - Messico 9
AT - Austria 8
CH - Svizzera 8
JP - Giappone 8
MA - Marocco 8
NL - Olanda 8
PL - Polonia 7
EC - Ecuador 6
LB - Libano 6
VE - Venezuela 6
CL - Cile 5
ID - Indonesia 5
IR - Iran 5
JO - Giordania 5
MY - Malesia 5
PH - Filippine 5
CZ - Repubblica Ceca 4
IL - Israele 4
KE - Kenya 4
PE - Perù 4
SA - Arabia Saudita 4
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
RO - Romania 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.343
Città #
Singapore 493
Chandler 326
Dublin 266
Hong Kong 199
San Jose 158
San Mateo 146
Jacksonville 139
Ashburn 96
Dong Ket 83
Santa Clara 81
Boardman 80
Perugia 79
Altamura 77
Beijing 68
Medford 63
Princeton 63
Moscow 60
Lawrence 57
Lauterbourg 52
Ann Arbor 51
Wilmington 51
Seoul 39
Ho Chi Minh City 37
New York 31
Andover 29
Hanoi 28
Des Moines 27
Munich 27
The Dalles 27
Los Angeles 24
Saint Petersburg 21
São Paulo 21
Helsinki 18
Dearborn 17
Piscataway 17
Frankfurt am Main 15
San Paolo di Civitate 12
Woodbridge 12
Izmir 11
Dallas 10
Turku 10
Brooklyn 9
Brussels 9
Da Nang 9
London 9
Norwalk 9
Falkenstein 8
Johannesburg 8
Tokyo 8
Ankara 7
Orem 7
Shanghai 7
Stockholm 7
Denver 6
Madrid 6
Nuremberg 6
Poplar 6
San Francisco 6
Tashkent 6
Baghdad 5
Belo Horizonte 5
Columbus 5
Curitiba 5
New Delhi 5
Toronto 5
Amsterdam 4
Auburn Hills 4
Bogotá 4
Campo Grande 4
Charlotte 4
Chennai 4
Delhi 4
Falls Church 4
Haiphong 4
Lahore 4
Medellín 4
Montreal 4
Olomouc 4
Ottawa 4
Phoenix 4
Rome 4
Roubaix 4
Santo André 4
Amelia 3
Amman 3
Aracaju 3
Atlanta 3
Bắc Ninh 3
Can Tho 3
Dakar 3
Guayaquil 3
Houston 3
Hải Dương 3
Islamabad 3
Istanbul 3
Kuala Lumpur 3
Lima 3
Menlo Park 3
Mexico City 3
Milan 3
Totale 3.407
Nome #
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 133
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 128
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 125
Nitric oxide and its antithrombotic action on the cardiovascular system 124
Platelets are essential for leukocyte recruitment in allergic inflammation. 121
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 116
Allergen induces the migration of platelets to lung tissue in allergic asthma. 112
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 111
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 111
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 111
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 110
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 109
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 108
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 108
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 106
Anti-platelet therapy: phosphodiesterase inhibitors. 106
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 106
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 104
Anti-platelet treatments in cancer: Basic and clinical research 102
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 100
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 98
Established and new antiplatelet therapies 93
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 92
Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. 91
Matrix metalloproteinases and peripheral arterial disease. 90
Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions 90
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. 89
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 87
Highly Active Antiretroviral Therapy-related Mechanisms of Endothelial and Platelets Function Alterations 87
Endothelium, venous thromboembolism and ischaemic cardiovascular events. 85
Chemotaxis and phagocytosis 84
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. 84
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice 83
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 83
Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. 83
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. 83
Platelet-targeted pharmacologic treatments as anti-cancer therapy 81
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. 80
Platelet Priming. 77
Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. 77
Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. 77
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 75
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 75
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 75
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2. 73
NCX4016: a novel antithrombotic agent. 71
Trombocitopenia da eparina nel paziente dializzato 71
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 68
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdum. 67
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. 67
Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis 66
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. 64
Platelets in respiratory disorders and inflammatory conditions. 63
Matrix Metalloproteinases and Platelet Function 63
Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. 60
Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies. 59
Platelets and chemotaxis. 57
Role of Platelets in the Pathogenesis of Osteoarthritis and Biological Effects of Hyaluronic Acid: in Vivo and in Vitro Study 55
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway 55
The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits 53
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 53
Stroke prevention: from available antiplatelet drugs to novel molecular targets. 49
Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. 48
Dicer Neosynthesis Regulates Platelet Reactivity: A Mechanism Altered in Type 2 Diabetes 28
Totale 5.460
Categoria #
all - tutte 23.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 0 0 0 0 15 46 92
2021/2022507 12 110 12 26 9 10 7 147 7 19 69 79
2022/20231.002 70 232 10 71 78 104 0 48 338 3 30 18
2023/2024381 19 42 18 5 2 4 99 9 46 12 77 48
2024/2025768 6 78 34 28 107 37 29 56 157 32 142 62
2025/20261.757 117 116 111 231 282 161 336 72 209 122 0 0
Totale 5.460